Peripheral
Neuropath
y
Presented by :
Zahraa Ismail, PGY2
Supervised by:
Dr Abdallah Rahbani
Definition:
Peripheral neuropathies encompass disorders of
peripheral nerves and fibers, manifesting secondary
to a wide range of pathologies.
The peripheral nerves comprise sensory, motor and
autonomic fibers.
classification:
 Based on anatomic pattern:
I. Mononeuropathy:
i. Simplex: involving only one nerve ( median nerve in carpal tunnel, peroneal nerve in drop foot,
etc)
ii. Multiplex : two or more large nerves that are not symmetrical (mononeuropathy multiplex)
II. Polyneuropathy: affects multiple nerves, most of the time, symmetrically
iii. Hereditary: ( CMT, HNPP, Refsum dz)
iv. Acquired :
a. Acute (<4 weeks)
b. Subacute (4–12 weeks)
c. Chronic (>12 weeks)
Pathophysiology :
Demyelinating Axonal
Signs and Symptoms:
Mononeuropathy Simplex:
A damage that occurs to a single nerve that
can be caused by a variety of factors including
trauma, compression and inflammation
Nerves that run close to the skin or near a bone
are most likely to be affected. These include:
• The median nerve in the wrist ( carpal tunnel
syndrome)
• The ulnar nerve in the elbow.
• The radial nerve in the upper arm.
• The peroneal nerve just below the knee.
• The lateral femoral cutaneous nerve in the
legs (meralgia paresthetica).
Mononeuropathy Multiplex :
Mononeuritis multiplex is an asymmetrical, asynchronous
sensory and motor peripheral neuropathy involving isolated
damage to at least 2 separate nerve areas. Multiple nerves in
random areas of the body can be affected
The condition is associated with systemic disorders
such as:
 Diabetes mellitus
 Vasculitis
 Amyloidosis
 Direct tumor involvement - Lymphoma,
leukemia
 Polyarteritis nodusa
 Rheumatoid arthritis
 Systemic lupus erythematosus
 Paraneoplastic syndromes
Hereditary polyneuropathy: Charcot Marie
Tooth
CMT is the most common inherited neuropathy
CMT is caused by pathogenic variants in
various genes leading to abnormalities either
in the peripheral nerves or the myelin sheath.
The most common initial presentation of
CMT is distal weakness and atrophy
manifesting with foot drop and pes cavus.
Sensory symptoms are often present but
tend to be less prominent in most CMT
subtypes. Later in the course, foot
deformities such as hammertoes ensue,
along with hand weakness and atrophy.
Hereditary polyneuropathy: Charcot Marie
Tooth
Hereditary polyneuropathy
● Hereditary neuropathy with tendencies to pressure palsies (HNPP)
● Refsum Diseases (a rare disorder of lipid metabolism)
● TTR amyloid polyneuropathy
Acquired polyneuropathy:
● Acute:
 Guillain-Barre syndrome:
o Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
o Acute Motor Axonal Neuropathy (AMAN)
o Acute Motor and Sensory Axonal Neuropathy (AMSAN)
o Miller Fisher Variant (GQ1b antibody)
● Chronic:
 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
 Metabolic polyneuropathy
 Toxic polyneuropathy
 Immune/inflammatory polyneuropathy
Guillain-Barre syndrome:
• The acute polyneuropathy of GBS is triggered
when an immune response to an antecedent
event cross-reacts with shared epitopes on
peripheral nerve (molecular mimicry).
• Most patients report an antecedent infection or
other event in the four weeks prior to GBS.
Upper respiratory tract infection and
gastroenteritis are the most common infections,
and Campylobacter jejuni gastroenteritis is the
most commonly identified precipitant of GBS.
• The typical clinical features of GBS include
progressive and symmetric muscle weakness
with absent or depressed deep tendon reflexes.
Patients may also have sensory symptoms and
dysautonomia. Symptoms typically progress over
a period of two weeks
• The weakness in GBS can vary from mild
difficulty with walking to near complete paralysis
of all limb, facial, respiratory, and bulbar
muscles, depending on disease severity and
Guillain-Barre syndrome :
GBS Variant
Type (Demyelinating
or Axonal)
Time of
Onset
Peak Time of
Symptoms
Symptoms Treatment Prognosis
AIDP (Acute
Inflammatory
Demyelinating
Polyneuropathy)
Demyelinating
Days to 4
weeks
2–4 weeks
Ascending weakness,
areflexia, mild sensory
loss
IVIG or Plasma
Exchange (PLEX),
supportive care
Good recovery in 6–12
months, ~80% fully recover
AMAN (Acute
Motor Axonal
Neuropathy)
Axonal
Days to 2
weeks
1–2 weeks
Pure motor weakness,
rapid progression, no
sensory loss
IVIG or PLEX,
respiratory support
if needed
Recovery varies; some
recover in months, others
have residual weakness
AMSAN (Acute
Motor and Sensory
Axonal
Neuropathy)
Axonal
Days to 2
weeks
1–2 weeks
Severe motor and
sensory loss, rapid
progression
IVIG or PLEX,
aggressive rehab
Poorer prognosis, often
prolonged recovery
Miller-Fisher
Syndrome (MFS)
Demyelinating
(some axonal
features)
Days to 2
weeks
2–4 weeks
Triad: Ophthalmoplegia,
ataxia, areflexia, minimal
limb weakness
IVIG or PLEX,
supportive care
Good recovery in weeks to
months
Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP):
• Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP) is a chronic, immune-
mediated peripheral nerve disorder
characterized by progressive or relapsing
weakness and sensory loss due to demyelination
of peripheral nerves.
• It’s caused by an autoimmune-mediated attack on
myelin sheath of peripheral nerves by T-cell activation
and autoantibody production
• Typical CIDP is characterized by a symmetric,
motor-predominant peripheral neuropathy that
causes both proximal and distal weakness, a
sensory impairment that is usually greater for
vibration and position sense than for pain and
temperature sense, and areflexia.
CIDP VS GBS
Feature
CIDP (Chronic Inflammatory
Demyelinating Polyneuropathy)
GBS (Guillain-Barré Syndrome)
Onset Slow, progressive (>8 weeks) Acute, rapid (days to 4 weeks)
Course Chronic, relapsing, or progressive Monophasic (one-time episode)
Pathogenesis
Autoimmune attack on myelin (chronic
inflammation)
Autoimmune attack on myelin or axons (acute
inflammation)
Weakness
Symmetric, proximal & distal,
progressive
Symmetric, ascending paralysis (legs → arms
→ face)
Reflexes
Absent or reduced
(hyporeflexia/areflexia)
Absent (areflexia)
Sensory Symptoms
Numbness, tingling,
vibration/proprioception loss
Mild sensory loss, tingling
Autonomic Dysfunction Less common (some cases) Common (BP fluctuations, arrhythmias)
Treatment
First-line: IVIG, Plasma Exchange
(PLEX), Corticosteroids
First-line: IVIG, Plasma Exchange (PLEX)
Metabolic polyneuropathy: Diabetic
• Diabetic polyneuropathy (DPN) is a chronic,
progressive nerve disorder caused by long-term
hyperglycemia, leading to peripheral nerve
damage. It is the most common metabolic
polyneuropathy and affects sensory, motor, and
autonomic nerves.
Hyperglycemia-induced nerve damage via:
• Oxidative stress → Mitochondrial dysfunction &
nerve injury
• Advanced glycation end-products (AGEs) →
Disrupt nerve function
• Microvascular damage → Reduced blood flow
to nerves
• Inflammatory processes → Chronic nerve
degeneration
Metabolic polyneuropathy: Diabetic:
Type Symptoms Affected Nerves
Distal Symmetric
Polyneuropathy (DSPN)
(Most common)
🔹 Stocking-glove pattern: Numbness, tingling,
burning pain in feet (then hands)
🔹 Loss of vibration & proprioception
🔹 Weakness in severe cases
Sensory > Motor
Autonomic Neuropathy
🔹 Orthostatic hypotension
🔹 Gastroparesis (nausea, bloating)
🔹 Bladder dysfunction
🔹 Erectile dysfunction
🔹 Sweating abnormalities
Autonomic nerves
(sympathetic &
parasympathetic)
Diabetic Amyotrophy
(Proximal Neuropathy)
🔹 Severe thigh, hip, or buttock pain
🔹 Weakness in proximal leg muscles
🔹 Muscle atrophy
Lumbar plexus (Femoral,
Obturator nerves)
Mononeuropathy (Focal
Neuropathy)
🔹 Sudden cranial or peripheral nerve palsies
(e.g., CN III, VI, VII)
🔹 Median nerve (carpal tunnel), Ulnar nerve
Single nerve involvement
Mononeuritis Multiplex
🔹 Asymmetric, painful weakness in multiple
nerves
🔹 Affects random nerves (e.g., peroneal →
foot drop, radial → wrist drop)
🔹 Can progress to distal symmetric
polyneuropathy if untreated
Multiple, patchy peripheral
nerves
Metabolic polyneuropathy: Vit B12 Deficiency
Vitamin B12 deficiency causes demyelination and
axonal degeneration of peripheral nerves, spinal
cord (posterior & lateral columns), and the brain,
leading to sensory, motor, and autonomic
dysfunction.
Common causes:
• Dietary deficiency (vegan diet)
• Malabsorption (pernicious anemia, gastric
bypass, Crohn’s disease)
• Medications (metformin, PPIs)
Metabolic polyneuropathy: Vit B12
Deficiency:
Category Symptoms Pathology
Sensory Symptoms
🔹 Glove-and-stocking sensory loss
🔹 Tingling, numbness, burning
🔹 Loss of proprioception & vibration →
Ataxia
Dorsal column demyelination
(posterior cord syndrome)
Motor Symptoms
🔹 Weakness (late-stage)
🔹 Spasticity & hyperreflexia in severe
cases
🔹 Positive Babinski sign
Lateral corticospinal tract
demyelination (upper motor
neuron involvement)
Autonomic Symptoms
🔹 Orthostatic hypotension
🔹 Bladder dysfunction
Peripheral & autonomic nerve
involvement
Neuropsychiatric
Symptoms
🔹 Memory loss, confusion
🔹 Depression, irritability
🔹 In severe cases: Dementia, psychosis
Brain involvement
Metabolic polyneuropathy: Vit B6 Deficiency:
Vitamin B6 (pyridoxine) deficiency leads to peripheral
neuropathy, characterized by sensory disturbances,
irritability, and in severe cases, seizures. It affects
both the central and peripheral nervous systems.
Common Causes:
• Malnutrition (alcoholism, chronic illness)
• Medications (Isoniazid, Hydralazine, Penicillamine,
Levodopa)
• Pregnancy & Dialysis (Increased B6 demand)
Other forms of acquired polyneuropathy:
● Toxic :
 Arsenic
 Lead
 Thallium
 Organophosphates
 Drug induced: chemotherapy, metronidazole, nitrofurantoin, lithium
● Immune/Inflammatory:
 Paraneoplastic
 Amyloidosis
 Sarcoidosis
 Paraproteinemic
● Small sensory fibers polyneuropathy ( ex: Fabry disease)
● Infectious polyneuropathy:
 HIV-Associated Neuropathy
 Leprosy (Hansen's Disease)
 Varicella Zoster Virus (VZV) Neuropathy
 Cytomegalovirus (CMV) Neuropathy
 Lyme Disease
 Hepatitis C Virus (HCV) Neuropathy
Skin Manifestations associated with
neuropathies
Type of Polyneuropathy Skin Manifestations
Diabetic Polyneuropathy
🔹 Dry, cracked skin
🔹 Hair loss on legs
🔹 Shiny, thin skin
🔹 Foot ulcers & poor wound healing
Vitamin B12 Deficiency
Neuropathy
🔹 Pale skin (pernicious anemia)
🔹 Glossitis (red, swollen tongue)
🔹 Hyperpigmentation (in some cases)
Toxic Neuropathy (e.g.,
Arsenic, Thallium)
🔹 Hyperpigmentation & Mees’ lines (arsenic
poisoning)
🔹 Alopecia (hair loss, thallium poisoning)
🔹 Exfoliative dermatitis
Alcoholic Neuropathy
🔹 Erythema of palms
🔹 Spider angiomas
🔹 Glossitis & cheilitis (due to vitamin
deficiencies)
Leprosy (Hansen’s
Disease) – Infectious
Neuropathy
🔹 Hypopigmented, anesthetic skin patches
🔹 Nodules, thickened skin
🔹 Loss of eyebrows (madarosis)
Fabry Disease (Genetic
Polyneuropathy)
🔹 Angiokeratomas (small red/purple skin spots)
🔹 Hypohidrosis (reduced sweating) Mees’ lines (arsenic poisoning)
Thank You !

Neuropathy classifications: introduction.pptx

  • 1.
    Peripheral Neuropath y Presented by : ZahraaIsmail, PGY2 Supervised by: Dr Abdallah Rahbani
  • 2.
    Definition: Peripheral neuropathies encompassdisorders of peripheral nerves and fibers, manifesting secondary to a wide range of pathologies. The peripheral nerves comprise sensory, motor and autonomic fibers.
  • 3.
    classification:  Based onanatomic pattern: I. Mononeuropathy: i. Simplex: involving only one nerve ( median nerve in carpal tunnel, peroneal nerve in drop foot, etc) ii. Multiplex : two or more large nerves that are not symmetrical (mononeuropathy multiplex) II. Polyneuropathy: affects multiple nerves, most of the time, symmetrically iii. Hereditary: ( CMT, HNPP, Refsum dz) iv. Acquired : a. Acute (<4 weeks) b. Subacute (4–12 weeks) c. Chronic (>12 weeks)
  • 4.
  • 5.
  • 6.
    Mononeuropathy Simplex: A damagethat occurs to a single nerve that can be caused by a variety of factors including trauma, compression and inflammation Nerves that run close to the skin or near a bone are most likely to be affected. These include: • The median nerve in the wrist ( carpal tunnel syndrome) • The ulnar nerve in the elbow. • The radial nerve in the upper arm. • The peroneal nerve just below the knee. • The lateral femoral cutaneous nerve in the legs (meralgia paresthetica).
  • 7.
    Mononeuropathy Multiplex : Mononeuritismultiplex is an asymmetrical, asynchronous sensory and motor peripheral neuropathy involving isolated damage to at least 2 separate nerve areas. Multiple nerves in random areas of the body can be affected The condition is associated with systemic disorders such as:  Diabetes mellitus  Vasculitis  Amyloidosis  Direct tumor involvement - Lymphoma, leukemia  Polyarteritis nodusa  Rheumatoid arthritis  Systemic lupus erythematosus  Paraneoplastic syndromes
  • 8.
    Hereditary polyneuropathy: CharcotMarie Tooth CMT is the most common inherited neuropathy CMT is caused by pathogenic variants in various genes leading to abnormalities either in the peripheral nerves or the myelin sheath. The most common initial presentation of CMT is distal weakness and atrophy manifesting with foot drop and pes cavus. Sensory symptoms are often present but tend to be less prominent in most CMT subtypes. Later in the course, foot deformities such as hammertoes ensue, along with hand weakness and atrophy.
  • 9.
  • 10.
    Hereditary polyneuropathy ● Hereditaryneuropathy with tendencies to pressure palsies (HNPP) ● Refsum Diseases (a rare disorder of lipid metabolism) ● TTR amyloid polyneuropathy
  • 11.
    Acquired polyneuropathy: ● Acute: Guillain-Barre syndrome: o Acute Inflammatory Demyelinating Polyneuropathy (AIDP) o Acute Motor Axonal Neuropathy (AMAN) o Acute Motor and Sensory Axonal Neuropathy (AMSAN) o Miller Fisher Variant (GQ1b antibody) ● Chronic:  Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)  Metabolic polyneuropathy  Toxic polyneuropathy  Immune/inflammatory polyneuropathy
  • 12.
    Guillain-Barre syndrome: • Theacute polyneuropathy of GBS is triggered when an immune response to an antecedent event cross-reacts with shared epitopes on peripheral nerve (molecular mimicry). • Most patients report an antecedent infection or other event in the four weeks prior to GBS. Upper respiratory tract infection and gastroenteritis are the most common infections, and Campylobacter jejuni gastroenteritis is the most commonly identified precipitant of GBS. • The typical clinical features of GBS include progressive and symmetric muscle weakness with absent or depressed deep tendon reflexes. Patients may also have sensory symptoms and dysautonomia. Symptoms typically progress over a period of two weeks • The weakness in GBS can vary from mild difficulty with walking to near complete paralysis of all limb, facial, respiratory, and bulbar muscles, depending on disease severity and
  • 13.
    Guillain-Barre syndrome : GBSVariant Type (Demyelinating or Axonal) Time of Onset Peak Time of Symptoms Symptoms Treatment Prognosis AIDP (Acute Inflammatory Demyelinating Polyneuropathy) Demyelinating Days to 4 weeks 2–4 weeks Ascending weakness, areflexia, mild sensory loss IVIG or Plasma Exchange (PLEX), supportive care Good recovery in 6–12 months, ~80% fully recover AMAN (Acute Motor Axonal Neuropathy) Axonal Days to 2 weeks 1–2 weeks Pure motor weakness, rapid progression, no sensory loss IVIG or PLEX, respiratory support if needed Recovery varies; some recover in months, others have residual weakness AMSAN (Acute Motor and Sensory Axonal Neuropathy) Axonal Days to 2 weeks 1–2 weeks Severe motor and sensory loss, rapid progression IVIG or PLEX, aggressive rehab Poorer prognosis, often prolonged recovery Miller-Fisher Syndrome (MFS) Demyelinating (some axonal features) Days to 2 weeks 2–4 weeks Triad: Ophthalmoplegia, ataxia, areflexia, minimal limb weakness IVIG or PLEX, supportive care Good recovery in weeks to months
  • 14.
    Chronic Inflammatory Demyelinating Polyneuropathy(CIDP): • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a chronic, immune- mediated peripheral nerve disorder characterized by progressive or relapsing weakness and sensory loss due to demyelination of peripheral nerves. • It’s caused by an autoimmune-mediated attack on myelin sheath of peripheral nerves by T-cell activation and autoantibody production • Typical CIDP is characterized by a symmetric, motor-predominant peripheral neuropathy that causes both proximal and distal weakness, a sensory impairment that is usually greater for vibration and position sense than for pain and temperature sense, and areflexia.
  • 15.
    CIDP VS GBS Feature CIDP(Chronic Inflammatory Demyelinating Polyneuropathy) GBS (Guillain-Barré Syndrome) Onset Slow, progressive (>8 weeks) Acute, rapid (days to 4 weeks) Course Chronic, relapsing, or progressive Monophasic (one-time episode) Pathogenesis Autoimmune attack on myelin (chronic inflammation) Autoimmune attack on myelin or axons (acute inflammation) Weakness Symmetric, proximal & distal, progressive Symmetric, ascending paralysis (legs → arms → face) Reflexes Absent or reduced (hyporeflexia/areflexia) Absent (areflexia) Sensory Symptoms Numbness, tingling, vibration/proprioception loss Mild sensory loss, tingling Autonomic Dysfunction Less common (some cases) Common (BP fluctuations, arrhythmias) Treatment First-line: IVIG, Plasma Exchange (PLEX), Corticosteroids First-line: IVIG, Plasma Exchange (PLEX)
  • 16.
    Metabolic polyneuropathy: Diabetic •Diabetic polyneuropathy (DPN) is a chronic, progressive nerve disorder caused by long-term hyperglycemia, leading to peripheral nerve damage. It is the most common metabolic polyneuropathy and affects sensory, motor, and autonomic nerves. Hyperglycemia-induced nerve damage via: • Oxidative stress → Mitochondrial dysfunction & nerve injury • Advanced glycation end-products (AGEs) → Disrupt nerve function • Microvascular damage → Reduced blood flow to nerves • Inflammatory processes → Chronic nerve degeneration
  • 17.
    Metabolic polyneuropathy: Diabetic: TypeSymptoms Affected Nerves Distal Symmetric Polyneuropathy (DSPN) (Most common) 🔹 Stocking-glove pattern: Numbness, tingling, burning pain in feet (then hands) 🔹 Loss of vibration & proprioception 🔹 Weakness in severe cases Sensory > Motor Autonomic Neuropathy 🔹 Orthostatic hypotension 🔹 Gastroparesis (nausea, bloating) 🔹 Bladder dysfunction 🔹 Erectile dysfunction 🔹 Sweating abnormalities Autonomic nerves (sympathetic & parasympathetic) Diabetic Amyotrophy (Proximal Neuropathy) 🔹 Severe thigh, hip, or buttock pain 🔹 Weakness in proximal leg muscles 🔹 Muscle atrophy Lumbar plexus (Femoral, Obturator nerves) Mononeuropathy (Focal Neuropathy) 🔹 Sudden cranial or peripheral nerve palsies (e.g., CN III, VI, VII) 🔹 Median nerve (carpal tunnel), Ulnar nerve Single nerve involvement Mononeuritis Multiplex 🔹 Asymmetric, painful weakness in multiple nerves 🔹 Affects random nerves (e.g., peroneal → foot drop, radial → wrist drop) 🔹 Can progress to distal symmetric polyneuropathy if untreated Multiple, patchy peripheral nerves
  • 18.
    Metabolic polyneuropathy: VitB12 Deficiency Vitamin B12 deficiency causes demyelination and axonal degeneration of peripheral nerves, spinal cord (posterior & lateral columns), and the brain, leading to sensory, motor, and autonomic dysfunction. Common causes: • Dietary deficiency (vegan diet) • Malabsorption (pernicious anemia, gastric bypass, Crohn’s disease) • Medications (metformin, PPIs)
  • 19.
    Metabolic polyneuropathy: VitB12 Deficiency: Category Symptoms Pathology Sensory Symptoms 🔹 Glove-and-stocking sensory loss 🔹 Tingling, numbness, burning 🔹 Loss of proprioception & vibration → Ataxia Dorsal column demyelination (posterior cord syndrome) Motor Symptoms 🔹 Weakness (late-stage) 🔹 Spasticity & hyperreflexia in severe cases 🔹 Positive Babinski sign Lateral corticospinal tract demyelination (upper motor neuron involvement) Autonomic Symptoms 🔹 Orthostatic hypotension 🔹 Bladder dysfunction Peripheral & autonomic nerve involvement Neuropsychiatric Symptoms 🔹 Memory loss, confusion 🔹 Depression, irritability 🔹 In severe cases: Dementia, psychosis Brain involvement
  • 20.
    Metabolic polyneuropathy: VitB6 Deficiency: Vitamin B6 (pyridoxine) deficiency leads to peripheral neuropathy, characterized by sensory disturbances, irritability, and in severe cases, seizures. It affects both the central and peripheral nervous systems. Common Causes: • Malnutrition (alcoholism, chronic illness) • Medications (Isoniazid, Hydralazine, Penicillamine, Levodopa) • Pregnancy & Dialysis (Increased B6 demand)
  • 21.
    Other forms ofacquired polyneuropathy: ● Toxic :  Arsenic  Lead  Thallium  Organophosphates  Drug induced: chemotherapy, metronidazole, nitrofurantoin, lithium ● Immune/Inflammatory:  Paraneoplastic  Amyloidosis  Sarcoidosis  Paraproteinemic ● Small sensory fibers polyneuropathy ( ex: Fabry disease) ● Infectious polyneuropathy:  HIV-Associated Neuropathy  Leprosy (Hansen's Disease)  Varicella Zoster Virus (VZV) Neuropathy  Cytomegalovirus (CMV) Neuropathy  Lyme Disease  Hepatitis C Virus (HCV) Neuropathy
  • 22.
    Skin Manifestations associatedwith neuropathies Type of Polyneuropathy Skin Manifestations Diabetic Polyneuropathy 🔹 Dry, cracked skin 🔹 Hair loss on legs 🔹 Shiny, thin skin 🔹 Foot ulcers & poor wound healing Vitamin B12 Deficiency Neuropathy 🔹 Pale skin (pernicious anemia) 🔹 Glossitis (red, swollen tongue) 🔹 Hyperpigmentation (in some cases) Toxic Neuropathy (e.g., Arsenic, Thallium) 🔹 Hyperpigmentation & Mees’ lines (arsenic poisoning) 🔹 Alopecia (hair loss, thallium poisoning) 🔹 Exfoliative dermatitis Alcoholic Neuropathy 🔹 Erythema of palms 🔹 Spider angiomas 🔹 Glossitis & cheilitis (due to vitamin deficiencies) Leprosy (Hansen’s Disease) – Infectious Neuropathy 🔹 Hypopigmented, anesthetic skin patches 🔹 Nodules, thickened skin 🔹 Loss of eyebrows (madarosis) Fabry Disease (Genetic Polyneuropathy) 🔹 Angiokeratomas (small red/purple skin spots) 🔹 Hypohidrosis (reduced sweating) Mees’ lines (arsenic poisoning)
  • 23.